Share
Market Research Report

ALPHA EMITTER MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Type of RadionuclideRadium (Ra-223) · Actinium (Ac-225) · Lead (Pb-212) · Astatine-211 · Bismuth-213 and Others
  • Published In29 Apr 2026
  • Report CodeCMI5534
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033

Detailed Segmentation:

  • Global Alpha Emitter Market, By Type of Radionuclide (Revenue, USD Mn, 2021 - 2033)

    • Radium (Ra-223)
    • Actinium (Ac-225)
    • Lead (Pb-212)
    • Astatine-211
    • Bismuth-213
    • Others
  • Global Alpha Emitter Market, By Source (Revenue, USD Mn, 2021 - 2033)

    • Natural Sources
      • Uranium-238
      • Radium-226
    • Artificially Produced Sources
      • Plutonium
      • Americium
      • Curium
      • Californium
  • Global Alpha Emitter Market, By Application (Revenue, USD Mn, 2021 - 2033)

    • Bone Metastases
    • Prostate Cancer
    • Neuroendocrine Tumors
    • Ovarian Cancer
    • Others
  • Global Alpha Emitter Market, By End User (Revenue, USD Mn, 2021 - 2033)

    • Hospitals
    • Specialty Clinics
    • Diagnostic Centers
    • Others
  • Global Alpha Emitter Market, By Region (Revenue, USD Mn, 2021 - 2033)

    • North America
      • By Type of Radionuclide:
        • Radium (Ra-223)
        • Actinium (Ac-225)
        • Lead (Pb-212)
        • Astatine-211
        • Bismuth-213
        • Others
      • By Source:
        • Natural Sources
          • Uranium-238
          • Radium-226
        • Artificially Produced Sources
          • Plutonium
          • Americium
          • Curium
          • Californium
      • By Application:
        • Bone Metastases
        • Prostate Cancer
        • Neuroendocrine Tumors
        • Ovarian Cancer
        • Others
      • By End User:
        • Hospitals
        • Specialty Clinics
        • Diagnostic Centers
        • Others
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Type of Radionuclide:
        • Radium (Ra-223)
        • Actinium (Ac-225)
        • Lead (Pb-212)
        • Astatine-211
        • Bismuth-213
        • Others
      • By Source:
        • Natural Sources
          • Uranium-238
          • Radium-226
        • Artificially Produced Sources
          • Plutonium
          • Americium
          • Curium
          • Californium
      • By Application:
        • Bone Metastases
        • Prostate Cancer
        • Neuroendocrine Tumors
        • Ovarian Cancer
        • Others
      • By End User:
        • Hospitals
        • Specialty Clinics
        • Diagnostic Centers
        • Others
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Type of Radionuclide:
        • Radium (Ra-223)
        • Actinium (Ac-225)
        • Lead (Pb-212)
        • Astatine-211
        • Bismuth-213
        • Others
      • By Source:
        • Natural Sources
          • Uranium-238
          • Radium-226
        • Artificially Produced Sources
          • Plutonium
          • Americium
          • Curium
          • Californium
      • By Application:
        • Bone Metastases
        • Prostate Cancer
        • Neuroendocrine Tumors
        • Ovarian Cancer
        • Others
      • By End User:
        • Hospitals
        • Specialty Clinics
        • Diagnostic Centers
        • Others
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Type of Radionuclide:
        • Radium (Ra-223)
        • Actinium (Ac-225)
        • Lead (Pb-212)
        • Astatine-211
        • Bismuth-213
        • Others
      • By Source:
        • Natural Sources
          • Uranium-238
          • Radium-226
        • Artificially Produced Sources
          • Plutonium
          • Americium
          • Curium
          • Californium
      • By Application:
        • Bone Metastases
        • Prostate Cancer
        • Neuroendocrine Tumors
        • Ovarian Cancer
        • Others
      • By End User:
        • Hospitals
        • Specialty Clinics
        • Diagnostic Centers
        • Others
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Type of Radionuclide:
        • Radium (Ra-223)
        • Actinium (Ac-225)
        • Lead (Pb-212)
        • Astatine-211
        • Bismuth-213
        • Others
      • By Source:
        • Natural Sources
          • Uranium-238
          • Radium-226
        • Artificially Produced Sources
          • Plutonium
          • Americium
          • Curium
          • Californium
      • By Application:
        • Bone Metastases
        • Prostate Cancer
        • Neuroendocrine Tumors
        • Ovarian Cancer
        • Others
      • By End User:
        • Hospitals
        • Specialty Clinics
        • Diagnostic Centers
        • Others
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Type of Radionuclide:
        • Radium (Ra-223)
        • Actinium (Ac-225)
        • Lead (Pb-212)
        • Astatine-211
        • Bismuth-213
        • Others
      • By Source:
        • Natural Sources
          • Uranium-238
          • Radium-226
        • Artificially Produced Sources
          • Plutonium
          • Americium
          • Curium
          • Californium
      • By Application:
        • Bone Metastases
        • Prostate Cancer
        • Neuroendocrine Tumors
        • Ovarian Cancer
        • Others
      • By End User:
        • Hospitals
        • Specialty Clinics
        • Diagnostic Centers
        • Others
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa